Romana Schirhagl

This paper demonstrates that membrane-domain-dissolving antibiotics can reverse β-lactam resistance in MRSA by dissolving membrane domains, as shown through multiple experimental methods.

This study designs a recombinant fusion protein vaccine targeting epitopes of two toxins from Clostridium perfringens and Clostridium novyi to enhance immunogenicity against livestock infections.